Advanced Enzyme Tech

298.25
+1.65
(0.56%)
Market Cap
3,336.84 Cr
EPS
11.92
PE Ratio
23.24
Dividend Yield
1.71 %
Industry
Healthcare
52 Week High
571.00
52 Week Low
257.90
PB Ratio
2.48
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
298.25
#1 3,336.84
#3 23.24
#1 660.50
#1 16.68
#1 137
#3 -8.47
57.16
40.00
67.49
#1 9.67
45.50
-13.00
3
-38.46
60.11
0.95
37.90
19.00
21.30
-66.19
1
#1 700.00
49.64
63.00
19.27
50.34
0.20
-92.86
0
0.20
58.17
Growth Rate
Revenue Growth
16.68 %
Net Income Growth
31.86 %
Cash Flow Change
0.72 %
ROE
23.49 %
ROCE
25.71 %
EBITDA Margin (Avg.)
13.60 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
69
71
75
81
95
91
60
87
76
99
108
109
105
105
102
113
111
113
113
112
116
121
139
135
138
128
135
135
123
143
151
150
154
164
175
167
162
156
177
Expenses
37
47
36
41
44
42
41
52
46
58
63
60
56
61
60
61
57
64
59
62
59
62
71
78
74
78
85
91
90
99
100
99
103
107
107
118
103
104
114
EBITDA
32
24
39
40
51
49
19
35
30
41
45
49
49
44
42
52
55
49
54
51
57
59
68
57
64
50
50
44
33
44
50
51
51
57
68
50
58
52
63
Operating Profit %
47 %
34 %
52 %
49 %
54 %
53 %
31 %
40 %
39 %
42 %
42 %
45 %
46 %
41 %
41 %
45 %
48 %
42 %
47 %
44 %
47 %
49 %
48 %
41 %
46 %
39 %
37 %
31 %
26 %
29 %
29 %
29 %
30 %
33 %
33 %
26 %
33 %
29 %
33 %
Depreciation
2
2
2
2
3
3
3
4
4
5
5
5
5
5
5
5
6
7
6
7
7
7
7
9
9
9
9
9
9
9
9
8
9
9
9
9
9
9
9
Interest
2
3
1
2
2
1
0
1
1
1
1
5
1
2
-0
1
1
1
1
1
1
0
0
0
1
0
0
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
28
19
35
36
46
45
16
30
25
36
39
40
42
37
37
47
48
42
47
43
50
52
61
48
55
41
41
34
24
34
41
42
41
48
59
40
49
42
53
Tax
9
5
15
13
18
16
1
8
9
13
12
11
11
11
11
13
14
10
12
11
15
13
17
14
15
11
13
9
6
8
13
10
12
13
16
10
14
9
14
Net Profit
19
15
21
23
28
29
14
22
16
22
27
28
31
26
25
34
34
32
35
33
35
39
44
34
40
30
29
25
18
26
28
32
29
35
43
30
35
33
39
EPS in ₹
8.30
6.65
9.15
10.75
12.76
13.17
1.24
8.94
1.46
1.96
2.26
2.44
2.66
2.21
2.19
2.89
2.99
2.77
3.01
2.81
3.07
3.33
3.86
2.81
3.40
2.65
2.46
2.19
1.60
2.34
2.63
2.87
2.58
3.08
3.74
2.53
3.05
2.94
3.36

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
416
451
589
732
811
979
1,156
1,268
1,422
1,536
Fixed Assets
282
286
421
491
496
563
604
619
649
650
Current Assets
104
140
138
211
282
376
516
604
722
810
Capital Work in Progress
9
7
8
11
11
10
10
15
22
41
Investments
0
0
0
0
111
124
121
102
360
403
Other Assets
125
158
160
230
194
282
420
531
392
442
Total Liabilities
416
451
589
732
811
979
1,156
1,268
1,422
1,536
Current Liabilities
131
111
62
99
65
60
68
60
78
106
Non Current Liabilities
69
56
42
51
41
52
56
67
60
58
Total Equity
216
283
485
582
705
867
1,033
1,140
1,284
1,371
Reserve & Surplus
190
256
442
537
657
817
949
1,066
1,213
1,302
Share Capital
22
22
22
22
22
22
22
22
22
22

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
21
-18
54
-38
60
109
75
-171
17
Investing Activities
-15
-10
-60
-60
-124
-43
-27
2
-286
-65
Operating Activities
54
93
107
116
129
141
163
122
140
141
Financing Activities
-36
-63
-65
-2
-43
-39
-26
-49
-26
-59

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
55.38 %
52.30 %
52.55 %
52.71 %
52.70 %
52.70 %
49.87 %
49.87 %
49.87 %
46.52 %
45.92 %
43.62 %
43.49 %
43.02 %
42.95 %
42.93 %
43.08 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
23.01 %
12.03 %
12.63 %
12.58 %
11.90 %
DIIs
7.29 %
8.23 %
8.32 %
8.50 %
6.46 %
6.05 %
5.36 %
5.64 %
5.73 %
7.59 %
5.84 %
5.42 %
7.56 %
8.08 %
8.02 %
8.18 %
8.19 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.51 %
14.31 %
15.31 %
14.87 %
15.21 %
15.14 %
13.37 %
13.43 %
13.28 %
14.23 %
15.28 %
15.90 %
15.43 %
16.42 %
16.04 %
16.11 %
16.68 %
Others
23.82 %
25.16 %
23.83 %
23.92 %
25.63 %
26.12 %
31.40 %
31.06 %
31.11 %
31.66 %
32.97 %
35.06 %
10.51 %
20.45 %
20.36 %
20.21 %
20.16 %
No of Share Holders
0
62,388
79,254
87,112
84,346
86,573
84,376
84,277
77,537
75,052
72,642
73,034
68,640
65,222
66,758
67,351
65,322

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 1 0.4 0.5 0.6 0.6 0.9 1 1 5.1 0.00
Dividend Yield (%) 0.24 0.19 0.27 0.42 0.17 0.32 0.42 0.29 1.83 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Intimation For Grant Of Stock Options Under Advanced Enzyme Technologies Limited - Employees Stock Option Scheme 2022 (The Scheme)Mar 27, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Integrated Filing (Financial)Feb 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 08, 2025
Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 08 2025Feb 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Board Meeting Intimation for Intimation Of Board Meeting And Closure Of Trading WindowFeb 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 06, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 13, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 05, 2024
Intimation - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Dec 05, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 29, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 19, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 09, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 09, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 09, 2024
Outcome Of Board Meeting Held On November 09, 2024Nov 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On November 09, 2024Nov 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2024
Board Meeting Intimation for Intimation Of Board Meeting And Closure Of Trading WindowOct 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 02, 2024
Intimation Under Regulation 30 Read With Schedule III Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 01, 2024

Technical Indicators

RSI(14)
Neutral
57.16
ATR(14)
Volatile
10.90
STOCH(9,6)
Overbought
83.42
STOCH RSI(14)
Overbought
85.79
MACD(12,26)
Bullish
2.96
ADX(14)
Weak Trend
17.72
UO(9)
Bearish
56.08
ROC(12)
Uptrend But Slowing Down
1.12
WillR(14)
Neutral
-20.37